Is There a Role for mTOR Inhibitors in Renal Transplantation?

被引：1
|
作者：
Zaltzman, Jeffrey Steven [1 ]
机构：
[1] Univ Toronto, St Michaels Hosp, Dept Med, Div Nephrol & Transplant, Toronto, ON, Canada
来源：
TRANSPLANTATION | 2017年 / 101卷 / 02期
关键词：
MAINTENANCE IMMUNOSUPPRESSION; KIDNEY-TRANSPLANTATION; RAPAMYCIN INHIBITORS; RECIPIENTS; EFFICACY; TARGET;
D O I：
10.1097/TP.0000000000001541
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：228 / 229
页数：2
相关论文
共 50 条
  • [21] DE NOVO THROMBOTIC MICROANGIOPATHY IN RENAL ALLOGRAFT RECIPIENTS: ROLE OF MTOR INHIBITORS
    Nava, Fabio
    Mori, Giacomo
    Ciaravello, Antonio
    Magnoni, Giacomo
    Facchini, Francesca
    Leonelli, Marco
    Cappelli, Gianni
    Bonucchi, Decenzio
    TRANSPLANT INTERNATIONAL, 2013, 26 : 258 - 258
  • [22] Dissecting the role of mTOR: Lessons from mTOR inhibitors
    Dowling, Ryan J. O.
    Topisirovic, Ivan
    Fonseca, Bruno D.
    Sonenberg, Nahum
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2010, 1804 (03): : 433 - 439
  • [23] Experience with mTOR inhibitors in pediatric liver transplantation
    Ozcay, Figen
    Baris, Zeren
    Gulsan, Meltem
    Moray, Gokhan
    Haberal, Mehmet
    TRANSPLANTATION, 2016, 100 (07) : S354 - S354
  • [24] COST-EFFECTIVENESS ANALYSIS OF THE EARLY CONVERSION OF TACROLIMUS TO MTOR INHIBITORS IN PATIENTS WITH RENAL TRANSPLANTATION
    Gamboa, O.
    Montero, C.
    Mesa, L.
    Benavides, C.
    Reino, A.
    Castillo, J. S.
    VALUE IN HEALTH, 2011, 14 (03) : A76 - A76
  • [25] Long-term side effects of treatment with mTOR inhibitors in children after renal transplantation
    Kranz, Birgitta
    Wingen, Anne-Margret
    Vester, Udo
    Koenig, Jens
    Hoyer, Peter F.
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1293 - 1298
  • [26] Long-term side effects of treatment with mTOR inhibitors in children after renal transplantation
    Birgitta Kranz
    Anne-Margret Wingen
    Udo Vester
    Jens König
    Peter F. Hoyer
    Pediatric Nephrology, 2013, 28 : 1293 - 1298
  • [27] THE USE OF MTOR INHIBITORS IN PEDIATRIC LIVER TRANSPLANTATION
    Brunati, Andrea
    Romagnoli, Renato
    Cerrina, Alessia
    Carbonaro, Giulia
    Calvo, Pier Luigi
    Dell'Olio, Dominic
    Salizzoni, Mauro
    TRANSPLANT INTERNATIONAL, 2013, 26 : 125 - 125
  • [28] The pros and the cons of mTOR inhibitors in kidney transplantation
    Ponticelli, Claudio
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2014, 10 (02) : 295 - 305
  • [29] mTOR inhibitors (mTOR-I) and proteinuria after lung transplantation
    Ussetti, P.
    Carreno, M. C.
    Garcia-Gallo, C.
    Laporta, R.
    Mora, G.
    Garcia-Fadul, C.
    Sanchez, B.
    Ferreiro, M. J.
    Varela, A.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S75 - S76
  • [30] Cancer and mTOR inhibitors in kidney transplantation recipients
    Kao, Chih-Chin
    Liu, Jia-Sin
    Chang, Yu-Kang
    Lin, Ming-Huang
    Lin, Yen-Chung
    Chen, Hsi-Hsien
    Chang, Wei-Chiao
    Hsu, Chih-Cheng
    Wu, Mai-Szu
    PEERJ, 2018, 6
12345